Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • foolishbrat
    Member
    • Nov 2008
    • 45

    Next Gen versus SAGE sequencing error

    Dear all,

    What's the primary difference between Next Gen Sequencing
    with SAGE in terms of sequencing error?

    In particular the errors affecting the tag counts.
  • westerman
    Rick Westerman
    • Jun 2008
    • 1104

    #2
    Originally posted by foolishbrat View Post
    Dear all,

    What's the primary difference between Next Gen Sequencing
    with SAGE in terms of sequencing error?

    In particular the errors affecting the tag counts.
    I think that you have rephrase your question to be more specific. I presume you are asking about the difference between doing expressing profiling with Next Gen sequencing versus doing profiling via SAGE with classical Sanger sequencing.

    Hands down a single Sanger read will be more accurate than a Next Gen read. That is one answer.

    However since Next gen platforms have many more reads per cost than Sanger you can
    sequence to a larger depth. If you are willing to throw away any next gen reads that do not have significant depth then your accuracy will go way up. So that may be your answer.

    The NextGen technology that you use will greatly influence the answer. I suspect that the SOLiD, despite not being the most accurate platform on a per-read basis, will be a good expression profiling platform simply due to the large quantity of reads at a low cost.

    Unfortunately I know of no papers that cover this question. I am not even sure if it is a question that someone would want to go through the effort of answering.

    Comment

    • Josliu
      Junior Member
      • Nov 2008
      • 4

      #3
      There are a few types of errors in the sequence tag counts for Next Gen sequence.
      1. The sequence basecall errors are high, .5%-1%. When we count the 17 base tags for long SAGE, we may have up to 17% errors or higher. Since different systems may have different error profiles, we may have difficulty to compare the results from one lab to another taken from different systems.
      2. The low abundant gene tags may be affected by the high abundant gene tags with tag sequences differing by 1 bps, since the expression ratio difference may be in seven orders of magnitude.
      3. We also have shot noise sqrt(N), N being the number of the tag. This will be problem to low abundant genes.
      4. Two or more genes may share the same tag. We have no way to tell how much is from one gene and how much is from the other gene(s).
      5. One gene might have two tags because of multiple isoforms. It is challenge to decide how to report them.
      6. Many gene tags are short then 17 bps such as 12 bps. We will have high errors to those genes in counting the tags.
      7. The errors may also come from the different channel locations in the flowcell.
      8. The enzyme efficiency might be dependent on the sequence contents.
      You may use NextGENe software to handle such problems. Generally the error will be minimum if the tag reach 500 counts.


      josliu

      Comment

      • foolishbrat
        Member
        • Nov 2008
        • 45

        #4
        Originally posted by Josliu View Post
        There are a few types of errors in the sequence tag counts for Next Gen sequence.
        1. The sequence basecall errors are high, .5%-1%. When we count the 17 base tags for long SAGE, we may have up to 17% errors or higher. Since different systems may have different error profiles, we may have difficulty to compare the results from one lab to another taken from different systems.
        2. The low abundant gene tags may be affected by the high abundant gene tags with tag sequences differing by 1 bps, since the expression ratio difference may be in seven orders of magnitude.
        3. We also have shot noise sqrt(N), N being the number of the tag. This will be problem to low abundant genes.
        4. Two or more genes may share the same tag. We have no way to tell how much is from one gene and how much is from the other gene(s).
        5. One gene might have two tags because of multiple isoforms. It is challenge to decide how to report them.
        6. Many gene tags are short then 17 bps such as 12 bps. We will have high errors to those genes in counting the tags.
        7. The errors may also come from the different channel locations in the flowcell.
        8. The enzyme efficiency might be dependent on the sequence contents.
        You may use NextGENe software to handle such problems. Generally the error will be minimum if the tag reach 500 counts.


        josliu
        Thanks so much for the reply. This is truly invaluable.

        Do you know any existing program/papers that does correction
        on on such tag counts error?

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        14 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        31 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        28 views
        0 reactions
        Last Post SEQadmin2  
        Working...